Association of an Androgen-Responsive T Cell Phenotype with Murine Diabetes and Idd2

References

• Krug J., Williams A., Beales P. E., Doniach I., Gale E. A., Pozzilli P. Parathyroiditis in the non‐obese diabetic mouse—a new finding. J. Endocrinol. 1991; 131: 193–196
   PubMed Web of Science ®Google Scholar
• Bernard N. F., Ertug F., Margolese H. High incidence of thyroiditis and anti‐thyroid autoantibodies in NOD mice. Diabetes 1992; 41: 40–46
   PubMed Web of Science ®Google Scholar
• Asamoto H., Oishi M., Akazawa Y., Tochino Y. Histological and immunological changes in the thymus and other organs in NOD mice. Insulitis and Type I Diabetes‐Lessons from the NOD Mouse, S. Trui, Y. Tochino, K. Nonaka. Academic Press, Tokyo 1986; 61
   Google Scholar
• Yagi H., Matsumoto M., Kunimoto K., Kawaguchi J., Makino S., Harada M. Analysis of the roles of CD4 + and CD8 + T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. European J. Immunol. 1992; 22: 2387–2393
   PubMed Web of Science ®Google Scholar
• Christianson S. W., Shultz L. D., Leiter E. H. Adoptive transfer of diabetes into immunodeficient NOD‐scid/scid mice. Relative contributions of CD4 + and CD8 + T cells from diabetic versus prediabetic NOD. NON‐Thy1a donors. Diabetes 1993; 42: 44–55
   PubMed Web of Science ®Google Scholar
• Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35: 855–860
   PubMed Web of Science ®Google Scholar
• Miller B. J., Appel M. C., O'Neil J. J., Wicker L. S. Both the Lyt‐2 + and L3T4 + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 1988; 140: 52–58
   PubMed Web of Science ®Google Scholar
• Bendelac A., Carnaud C., Boitard C., Bach J. F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4 + and Lyt‐2 + T cells. J. Exp. Med. 1987; 166: 823–832
   PubMed Web of Science ®Google Scholar
• Hutchings P. R., Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmunity 1990; 3: 175–185
   PubMed Web of Science ®Google Scholar
• Chosich N., Harrison N. C. Suppression of diabetes mellitus in the non‐obese diabetic (NOD) mouse by an autoreactive (anti‐I‐Ag7) islet‐derived CD4 + T cell line. Diabetologia. 1993; 36: 716–721
   PubMedGoogle Scholar
• Boitard C., Yasunami R., Dardenne M., Bach J. F. T cell‐mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 1989; 169: 1669–1680
   PubMed Web of Science ®Google Scholar
• Dardenne M., Lepault F., Bendelac A., Bach J. F. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. European J. Immunol. 1989; 19: 889–895
   PubMedGoogle Scholar
• Pearce R. B., Peterson C M. Studies of concanavalin A in nonobese diabetic mice. I. Prevention of insulin‐dependent diabetes. J. Pharm. Exp. Ther. 1991; 258: 710–715
   PubMedGoogle Scholar
• Pozzilli P., Signore A., Williams A. J., Beales P. E. NOD mouse colonies around the world—recent facts and figures. Immunology Today 1993; 14: 193–196
   PubMedGoogle Scholar
• Inman R. D. Immunological sex differences and the female predominance of systemic lupus erythematosus. Arthritis Rheum. 1978; 21: 849–852
   PubMed Web of Science ®Google Scholar
• Steven M. M. Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann. Rheum. Dis. 1992; 51: 186–194
   PubMed Web of Science ®Google Scholar
• Duquette P., Pleines J., Girard M., Charest L., Senecal‐Quevillon M., Masse C. The increased susceptibility of women to multiple sclerosis. Can. J. Neurol. Sci. 1992; 19: 466–471
   PubMed Web of Science ®Google Scholar
• Fitzpatrick F., Lepault F., Homo‐Delarche F., Bach J. F., Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Enodcrinol. 1991; 129: 1382–1390
   PubMed Web of Science ®Google Scholar
• Makino S., Kunimoto K., Muraoka Y., Katagiri K. Effect of castration on the appearance of diabetes in NOD mouse. Jikken Dobutsu. Exper. Animals. 1981; 30: 137–140
   PubMedGoogle Scholar
• Fox H. S. Androgen treatment prevents diabetes in nonobese diabetic mice. J. Exp. Med. 1992; 175: 1409–1412
   PubMed Web of Science ®Google Scholar
• Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative micro‐assay for activity. J. Immunol. 1978; 120: 2027–2032
   PubMed Web of Science ®Google Scholar
• Dietrich W. F., Miller J. C., Steen R. G., Merchant M., Damron D., Nahf R., Gross A., Joyce D. C., Wessel M., Dredge R. D., Marquis A., Stein L. D., Goodman N., Page D. C., Lander E. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nature Genetics 1994; 7: 220–245
   PubMed Web of Science ®Google Scholar
• Pearce R. B., Trigler L., Svaasand E. K., Peterson C. M. Polymorphism in the mouse Tap‐1 gene. Association with abnormal CD8 + T cell development in the nonobese non‐diabetic mouse. J. Immunol. 1993; 151: 5338–5347
   Google Scholar
• Prochazka M., Leiter E. H., Serreze D. V., Coleman D. L. Three recessive loci required for insulin‐dependent diabetes in nonobese diabetic mice. Science 1987; 237: 286–289
   PubMed Web of Science ®Google Scholar
• Prins J. B., Todd J. A., Rodrigues N. R., Ghosh S., Hogarth P. M., Wicker L. S., et al. Linkage on chromosome 3 of autoimmune diabetes and defective Fe receptor for IgG in NOD mice. Science 1993; 260: 695–698
   PubMed Web of Science ®Google Scholar
• Todd J. A., Aitman T. J., Cornall R. J., Ghosh S., Hall J. R., Hearne C. M., et al. Genetic anlaysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991; 351: 542–547
   PubMed Web of Science ®Google Scholar
• Prochazka M., Serreze D. V., Worthen S. M., Leiter E. H. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. Diabetes 1989; 38: 1446–1455
   Google Scholar
• Seino H., Takahashi K., Satoh J., Zhu X. P., Sagara M., Masuda T., et al. Prevention of autoimmune diabetes with lymphotoxin in NOD mice. Diabetes 1993; 42: 398–404
   Google Scholar
• Zipris D., Lazarus A. H., Crow A. R., Hadzija M., Delovitch T. L. Defective thymic T cell activation by concanavalin A and anti‐CD3 in autoimmune nonobese diabetic mice: Evidence for thymic T cell anergy that correlates with the onset of insulitis. J. Immunol. 1991; 146: 3763–3771
   PubMed Web of Science ®Google Scholar
• Leiter E. H., Prochazka M., Coleman D. L., Serreze D. V., Shultz L. D. Genetic factors predisposing to diabetes susceptibility in mice. The Immunology of Diabetes Mellitus, M. A. Jaworski, et al. Elsevier Science Publishers B. V. (Biomedical Division). 1987; 29
   Google Scholar
• Satoh J., Shintani S., Nobunaga T., Sugawara S., Makino S., Toyota T., Goto Y. NOD mice with high incidence of type 1 diabetes are not T lymphocytopenic. Tohoku J. Exp. Med. 1988; 155: 151–158
   Google Scholar
• Prochazka M., Serreze D. V., Frankel W. N., Leiter E. H. NOR/Lt mice: MHC‐matched diabetes‐resistant control strain for NOD mice. Diabetes. 1992; 41: 98–106
   PubMed Web of Science ®Google Scholar
• Roubinian J., Talal N., Siiteri P. K., Sadakian J. A. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arth. Rheum. 1979; 22: 1162–1169
   PubMed Web of Science ®Google Scholar
• Roubinian J. R., Talal N., Greenspan J. S., Goodman J. R., Siiteri P. K. Effect of castration and sex hormone treatment on survival, anti‐nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 1978; 147: 1568–1583
   PubMed Web of Science ®Google Scholar
• Sato E. H., Ariga H., Sullivan D. A. Impact of androgen therapy in Sjøgren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp‐lpr/lpr mice. Invest. Ophthalmol. Vis. Sci. 1992; 33: 2537–2545
   PubMedGoogle Scholar
• Vendramini A. C., Soo C., Sullivan D. A. Testosterone‐induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjøgren's syndrome. Invest. Ophthalmol Vis. Sci. 1991; 32: 3002–3006
   PubMed Web of Science ®Google Scholar
• Adkins B., Ghanei A., Hamilton K. Developmental regulation of IL‐4, IL‐2, and IFN‐γ production by murine peripheral T lymphocytes. J. Immunol. 1993; 151: 6617–6626
   PubMedGoogle Scholar
• Fitch F. W., McKisic M. D., Lancki D. W., Gajewski T. F. Differential regulation of murine lymphocyte subsets. Ann. Rev. Immunol. 1993; 11: 29–48
   PubMed Web of Science ®Google Scholar
• Araneo B. A., Dowell T., Diegel M., Daynes R. A. Dihy‐drotestosterone exerts a depressive influence on the production of interleukin‐4 (IL‐4), IL‐5, and IFN‐γ, but not IL‐2 by activated murine T cells. Blood 1991; 78: 688–699
   PubMed Web of Science ®Google Scholar
• Daynes R. A., Dudley D. J., Araneo B. A. Regulation of murine lymphokine production in vivo. II. Dehydroepi‐androsterone is a natural enhancer of interleukin 2 synthesis by helper T cells. European J. Immunol. 1990; 20: 793–802
   PubMed Web of Science ®Google Scholar
• Rocha B., Bandeira A. Limiting dilution analysis of interleukin‐2‐producing mature T cells. Interleukin 2 secretion is an exclusive property of L3T4 + lymphocytes. Scand. J. Immunol. 1988; 27: 47–57
   Google Scholar
• Ghosh S., Palmer S. M., Rodrigues N. R., Cordell H. J., Hearne C. M., Cornall R. J., et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genetics 1993; 4: 404–409
   PubMed Web of Science ®Google Scholar
• Olsen N. J., Watson M. B., Kovacs J. W. Studies of immunological function in mice with defective androgen action: Distinction between alterations in immune function due to hormonal insensitivity and alterations due to other genetic factors. Immunology 1991; 73: 52–57
   Google Scholar
• Anderson J. T., Cornelius J. G., Jarpe A. J., Winter W. E., Peck A. B. Insulin‐dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity 1993; 15: 113–122
   PubMed Web of Science ®Google Scholar
• Wogensen L., Huang X., Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J. Exp. Med. 1993; 178: 175–185
   PubMed Web of Science ®Google Scholar
• Magilavy D. B., Foys K. M., Gajewski T. F. Liver of MRL/lpr mice contain interleukin‐4‐producing lymphocytes and accessory cells that support the proliferation of Th2 helper T lymphocyte clones. European J. Immunol. 1992; 22: 2359–2365
   Google Scholar
• Chu E. B., Ernst D. N., Hobbs M. V., Weigle W. O. Maturational changes in CD4 + T‐cell subsets and lymphokine production in BXSB Mice. J. Immunol. 1994; 152: 4129–4138
   PubMed Web of Science ®Google Scholar
• Schurmans S., Heusser C. H., Qin H. Y., Merino J., Brighouse G., Lambert P. H. In vivo effects of anti‐IL‐4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J. Immunol. 1990; 145: 2465–2473
   PubMedGoogle Scholar